NDI-Lyso

CAT: 0931-TP2920-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0931-TP2920-01Size:10 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
2999646-19-2
Target
Apoptosis|||Caspase
Related Pathways
Proteases/Proteasome|||Apoptosis
Bioactivity
NDI-Lyso is an anticancer agent targeting lysosomes, functioning through an enzyme-induced self-assembly (EISA) mechanism catalyzed by Cathepsin B. In cancer cell lysosomes, it forms rigid long fibers, promoting lysosomal swelling, lysosomal membrane permeabilization (LMP), and membrane disruption. This leads to non-classical caspase-independent apoptosis (Apoptosis) . NDI-Lyso demonstrates significant selective anticancer activity across various cancer cell lines and drug-resistant cancer cells (IC50 approximately 10 ?M), while exhibiting low toxicity to normal cells (IC50 > 60 ?M) .
Smiles
O=C1C=2C3=C4C(C(=O)N(CCCCCC)C(=O)C4=CC2)=CC=C3C(=O)N1CCC(N[C@H](C(N[C@@H](CC5=CC=CC=C5)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCCCN)C(O)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)=O)CC6=CC=CC=C6)=O
Molecular Formula
C71H100N22O13
Molecular Weight
1469.69
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Popular Products